Ala Shahram, Maleki Iradj, Sanjari Araghi Ali, Sahebnasagh Adeleh, Shahraki Anahita
Pharmaceutical Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Internal Medicine, Imam Khomeini Hospital, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Caspian J Intern Med. 2020;11(2):143-149. doi: 10.22088/cjim.11.2.143.
To investigate the possibility that the eradication of infection is associated with a reduction in the risk of glaucoma.
Sixty-five successive patients with elevated intraocular pressure (IOP) or glaucoma were included in the study. Serum samples from all subjects were analyzed for the presence of - antibodies using ELISA. Forty patients with positive serologic test were included. Half of the patients enrolled into intervention group and the other half registered as control. Intervention arm was referred to the Gastroenterology Clinic for eradication of and evaluated for the effect of regimen eradication on IOP and glaucoma over 2 months of follow-up. The age-matched controls did not receive treatment. Urea breath test was applied to confirm eradication.
There was a significant (p=0.005) reduction in IOP after complete eradication in the intervention group. This value was not significant in control patients (p=0.08). The mean IOP before treatment of glaucoma in the control group was 23.60±2.37 mmHg and after treatment with anti-glaucoma drugs was 14.25±1.48 mmHg on the onset of study, and 13.55±2.01 mmHg after follow up. The mean IOP before treatment of glaucoma in the intervention group was 24.55±3.6 mmHg and after treatment with anti-glaucoma drugs was 15.15±1.8 mmHg, and 14.3±1.6 mmHg after the eradication of H pylori with a drug regimen. However, after the treatment of glaucoma in all patients, the overall comparison of mean IOP differences showed no statistical difference (P=0.65).
eradication therapy may have a positive effect on the management of glaucoma.
探讨根除感染与降低青光眼风险之间的关联可能性。
本研究纳入了65例连续的眼压升高(IOP)或青光眼患者。使用酶联免疫吸附测定(ELISA)分析所有受试者的血清样本中是否存在抗体。40例血清学检测呈阳性的患者被纳入研究。其中一半患者进入干预组,另一半登记为对照组。干预组患者被转诊至胃肠病诊所进行根除治疗,并在2个月的随访期间评估根除治疗方案对眼压和青光眼的影响。年龄匹配的对照组未接受治疗。应用尿素呼气试验确认根除情况。
干预组在完全根除后眼压有显著降低(p = 0.005)。对照组患者的这一数值无显著差异(p = 0.08)。在研究开始时,对照组青光眼治疗前的平均眼压为23.60±2.37 mmHg,使用抗青光眼药物治疗后为14.25±1.48 mmHg,随访后为13.55±2.01 mmHg。干预组青光眼治疗前的平均眼压为24.55±3.6 mmHg,使用抗青光眼药物治疗后为15.15±1.8 mmHg,采用药物方案根除幽门螺杆菌后为14.3±1.6 mmHg。然而,在所有患者的青光眼治疗后,平均眼压差异的总体比较无统计学差异(P = 0.65)。
根除治疗可能对青光眼的治疗有积极作用。